In vitro Test of Aspirin, Conventional Immediate Release vs. Sustained Release Tablet

Sustained-release tablets have emerged as a crucial advancement in pharmaceutical technology, offering improved drug delivery and therapeutic outcomes compared to conventional immediate-release formulations. This abstract highlights the sustained-release tablet's key attributes and significance in enhancing drug performance and patient compliance. Comparative studies between aspirin sustained-release and conventional-release tablets provide insights into their differing pharmacokinetic profiles and clinical impacts. Sustained-release formulations may offer prolonged pain relief, more stable antiplatelet effects, and reduced risk of gastrointestinal irritation compared to immediate-release tablets. Nevertheless, immediate-release aspirin might retain advantages in situations requiring rapid pain relief or acute antiplatelet effects.</p